Application of nanotechnology for the production of masculinized Tilapia, Oreochromis niloticus (Linnaeus, 1758)

Phylogenomic and expression analysis of Colossoma macropomum cyp19a1a and cyp19a1b and their non-classical role in tambaqui sex differentiation

“…However, none of the treatments changed the expression of esr2a and nor were able to distress the sex ratio in tambaqui. Such data is contradictory to the masculinization effect of aromatase inhibitors widely reported in a variety of fish species (Babiak et al, 2012, Shen et al, 2015, Evliyaoglu et al, 2019, Qin et al, 2020, Ayobahan et al, 2020, even at very low concentrations (Muth-Köhne et al, 2016, Joshi et al, 2019. And also incompatible to the tamoxifen effect that, acting as either agonist or antagonist, stimulating or inhibiting gonadal differentiation, leads to abnormal sexual development and biased sex ratio (Singh et al, 2012, Navarro-Martín et al, 2009, Singh et al, 2015, García-Hernández et al, 2016, Pandit et al, 2017.…”

Nanotechnology in reproduction, breeding and conservation of fish biodiversity: Current status and future potential

“…Poly lactic‐ co ‐glycolic acid (PLGA) NPs (136 nm) loaded with fadrozole (FZ) were orally fed to tilapia ( Oreochromis niloticus ) for the production of an all‐male population 24 . The results indicated that fish either fed with a high dosage of FZ alone or at a low dosage with NPs gave similar results indicating the importance of NPs in the dose reduction in drugs.…”

Applications of Nanotechnology in Fish Health

“…The poly lactic-co-glycolic acid nanoparticles were loaded with fadrozole (an inhibitor of estrogen synthesis), incorporated in the feed of Oreochromis niloticus, fed through a nano-drug delivery system. These fadrozole loaded nano-carriers inhibited the production of estrogen hormone in the fish, thereby, producing 100% masculinization of tilapia that attained their marketable size without premature spawning (Joshi et al 2019).…”